Thermochemoradiotherapy using superselective intra-arterial infusion for N3 cervical lymph node metastases of tongue cancer

J Cancer Res Ther. 2013 Oct-Dec;9(4):718-20. doi: 10.4103/0973-1482.126465.

Abstract

A case of squamous cell carcinoma of the tongue with advanced N3 cervical lymph node metastases in an 80-year-old female is reported. The patient was treated with a combination of radiotherapy (2 Gy/day, total 60 Gy), superselective intra-arterial chemotherapy via a superficial temporal artery and a femoral artery (docetaxel, total 124 mg; cisplatin, total 135 mg), and four sessions of hyperthermia for cervical lymph node metastases. The tumor responded well to therapy, and 18-fluorodeoxyglucose uptake in both primary and neck lesions disappeared on positron emission tomography-computed tomography. The patient has shown no clinical or radiological evidence of local recurrence or distant metastases 6 years after the end of treatment. Advanced oral cancer patients with N3 cervical lymph node metastases are particularly difficult to treat and have a poor prognosis. This method of thermochemoradiotherapy seems a promising modality for patients with N3 cervical lymph node metastases of oral cancer.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / radiotherapy*
  • Cervix Uteri / pathology
  • Chemoradiotherapy
  • Cisplatin / therapeutic use
  • Combined Modality Therapy
  • Docetaxel
  • Female
  • Humans
  • Hyperthermia, Induced
  • Infusions, Intra-Arterial
  • Lymph Nodes / pathology
  • Lymphatic Metastasis / radiotherapy*
  • Neoplasm Recurrence, Local / pathology
  • Positron-Emission Tomography
  • Taxoids / therapeutic use
  • Tongue Neoplasms / drug therapy*
  • Tongue Neoplasms / radiotherapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Taxoids
  • Docetaxel
  • Cisplatin